Insects modified in the laboratory – weapons of war against humanity?

11.07.2024 | www.kla.tv/29709

Since October 2023, Brazil has experienced the largest nationwide dengue fever outbreak in its history. Almost all states are affected and a state of emergency has been declared in several regions. The British daily newspaper "Financial Times" reported on June 2, 2024 that 5.5 million infections have been registered so far. Dengue, which can cause high fever, muscle pain and internal bleeding, has already caused more than 3,200 deaths this year. As has been known for years, laboratory-modified mosquitoes are being released in various countries around the world, and especially in Brazil, to combat infectious diseases. The United Nations World Mosquito Program announced last year that it would release billions of bred mosquitoes in various locations in Brazil over the next ten years. The research method used involves infecting Asian tiger mosquitoes with the naturally occurring Wolbachia bacterium and releasing them into a native mosquito population. The Wolbachia bacterium is intended to prevent dengue, Zika and other viruses from being transmitted by mosquitoes to other mosquitoes and consequently to the surrounding human population. The Brazilian health authority has already tested the release of laboratory mosquitoes in five major cities in Brazil. But what were the consequences of this release? At least the current figures show that there has been no reduction in the number of cases of dengue fever, but rather a record increase. A look into the past shows that previous research projects to contain infectious diseases caused by genetically modified mosquitoes have not been effective. For example, the British biotechnology company Oxitec released more than twelve million genetically modified mosquitoes in Brazil between 2013 and 2015. The aim of this field trial was to contain the population of the tiger mosquito "Aedes aegypti", which is particularly responsible for transmitting dengue fever. But 30 months later, genetic changes were also found in up to 60% of local mosquitoes. But not only that, the targeted and initially achieved reduction in the tiger mosquito population has returned to its previous level after 18 months. A cross between the natural and the genetically modified mosquito occurred, resulting in a more robust population of mosquitoes than before the release. In addition, research results have shown that the mosquitoes before and after the experiment are equally capable of carrying infectious diseases. Although the experiments to date have completely missed their target, production in the mosquito factories in Brazil has not been stopped. This raises the question of what interests are behind the research projects and who is financing their implementation? As early as 2019, the World Mosquito Program published on its website that the Bill & Melinda Gates Foundation and the Wellcome Trust are supporting the research project related to the Wolbachia bacterium with 50 million dollars. The Bill & Melinda Gates Foundation funded research into the dengue vaccine as early as 2003. The vaccine is manufactured by the Japanese pharmaceutical company Takeda, which also received a double-digit million amount from the Gates Foundation. But it is not just Bill Gates, other organizations are also supporting research projects related to laboratory-modified insects. For example, the organization Management Sciences for Health was already working on a study in 2022 to find out what countries around the world are willing to pay to use the new pathogen called Wolbachia. According to its own information, Management Sciences for Health is supported by various organizations, universities and private companies. Among others by: • the Bill & Melinda Gates Foundation • the pharmaceutical and biotechnology group Pfizer • the Asian pharmaceutical company Takeda, which produces vaccines to combat dengue • the global health initiative Unitaid • and the World Health Organization A look at the Brazilian scientific institution Oswaldo Cruz Foundation (FIOCRUZ for short), which is driving mosquito production, also reveals an astonishing network of relationships with various organizations and universities. The following are worth highlighting: • the World Bank • the United Nations • the United Nations Children's Fund, or UNICEF • the World Health Organization As a look at Brazil shows, research projects on laboratory-modified mosquitoes have not been stopped, although it is known that they fail to achieve their goal. Despite a lack of success and no discernible decline in infectious diseases, billions more mosquitoes are being released, resulting in massive financing costs and an increase in diseases..nesses and deaths. What is behind this economic model? Should mosquitoes be used as a weapon of war against humanity in the future? One conclusion remains: people are being massively harmed in the countries where the mosquitoes are released. As early as July 2023, Kla.TV founder Ivo Sasek warned of the increasing worldwide release of genetically modified mosquitoes. Due to the current events in Brazil, Kla.TV is broadcasting his speech from that time again. Hear amazing facts below, but also the first astonishing solutions

from db/rw

Sources/Links: Kla.TV-Sendungen zum Thema gentechnisch veränderte Insekten www.kla.tv/26586
www.kla.tv/26594
Größter Dengue-Ausbruch https://www.tagesschau.de/multimedia/video/video-1317230.html
https://www.ft.com/content/b253bc83-03fe-4f58-95c9-e5c805742009
In Brasilien gezüchtete Mücken https://www.spiegel.de/ausland/dengue-wie-in-brasilien-gezuechtete-super-muecken-das-denguefieber-bekaempfen-sollen-a-6fa51f86-c0c4-4c7a-8f4a-2f5c95eb2021
Genveränderung bei natürlichen Mücken nach Oxitec-Experiment https://www.dw.com/de/genver%C3%A4nderte-m%C3%BCcken-vermehren-sich-in-brasilien/a-50399709
https://www.nature.com/articles/s41598-019-49660-6
https://www.dw.com/de/genver%C3%A4nderte-m%C3%BCcken-vermehren-sich-in-brasilien/a-50399709
Mückenfabrik in Brasilien https://www.pharmazeutische-zeitung.de/muecken-aus-der-fabrik-gegen-denguefieber-139637/
https://msh.org/de/story/wolbachia-a-novel-method-for-controlling-mosquitoes-to-tame-the-spread-of-dengue/
Finanzierung durch die Bill & Melinda Gates Foundation und den Welcome Trust https://uncutnews.ch/nachdem-bill-gates-milliarden-gentechnisch-veraenderter-moskitos-freigesetzt-hat-breitet-sich-das-dengue-virus-aus/
https://www-worldmosquitoprogram-org.translate.goog/en/news-stories/news/world-mosquito-program-welcomes-aud50m-gates-foundation-and-wellcome-trust?_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=de
https://www.gatesfoundation.org/ideas/media-center/press-releases/2003/09/dengue-vaccine-research
https://www.takeda.com/newsroom/newsreleases/2016/takeda-receives-
$38-million-grant-from-the-bill--melinda-gates-foundation-to-support-polio-eradication-in-developing-countries/ Wolbachia-Mücken https://msh.org/de/story/wolbachia-a-novel-method-for-controlling-mosquitoes-to-tame-the-spread-of-dengue/
https://msh.org/de/partner-with-us/
Organisation FIOCRUZ https://portal.fiocruz.br/en/organizations-and-institutions
Impfstoffherstellerin Takeda https://www.pei.de/DE/newsroom/hp-meldungen/2022/221019-zulassung-impfstoff-dengue-fieber-empfohlen.html